Veterinary Medicines Information website

ESPECTINOMICINA 300 mg/g GANADEXIL POLVO PARA ADMINISTRACIÓN EN AGUA DE BEBIDA

Authorised
  • Spectinomycin dihydrochloride pentahydrate

Product identification

Medicine name:
ESPECTINOMICINA 300 mg/g GANADEXIL POLVO PARA ADMINISTRACIÓN EN AGUA DE BEBIDA
Active substance:
  • Spectinomycin dihydrochloride pentahydrate
Target species:
  • Pig
  • Turkey
  • Chicken
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Spectinomycin dihydrochloride pentahydrate
    300.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Pig
      • Meat and offal
        6
        day
    • Turkey
      • Meat and offal
        5
        day
      • Eggs
        no withdrawal period
    • Chicken
      • Meat and offal
        5
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XX04
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industrial Veterinaria S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 485 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024